Xanthone glucoside 2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one binds to the ATP-binding pocket of glycogen synthase kinase 3β and inhibits its activity: implications in prostate cancer and associated cardiovascular disease risk

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Ali, S. K., Sneha, P., Priyadharshini Christy, J., Zayed, H., & George Priya Doss, C. (2017). Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. Journal of Biomolecular Structure & Dynamics, 35(12), 2714–2724. https://doi.org/10.1080/07391102.2016.1229634
   PubMed Web of Science ®Google Scholar
• Aoki, M., Yokota, T., Sugiura, I., Sasaki, C., Hasegawa, T., Okumura, C., Ishiguro, K., Kohno, T., Sugio, S., & Matsuzaki, T. (2004). Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 3), 439–446. https://doi.org/10.1107/s090744490302938x
   PubMedGoogle Scholar
• Arfeen, M., Patel, R., Khan, T., & Bharatam, P. V. (2015). Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity. Journal of Biomolecular Structure & Dynamics, 33(12), 2578–2593. https://doi.org/10.1080/07391102.2015.1063457
   PubMed Web of Science ®Google Scholar
• Arnost, M., Pierce, A., ter Haar, E., Lauffer, D., Madden, J., Tanner, K., & Green, J. (2010). 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta. Bioorganic & Medicinal Chemistry Letters, 20(5), 1661–1664. https://doi.org/10.1016/j.bmcl.2010.01.072
   PubMed Web of Science ®Google Scholar
• Baker, D. (2001). Comparison of upper-body strength and power between professional and college-aged rugby league players. Journal of Strength and Conditioning Research, 15(1), 30–35.
   PubMed Web of Science ®Google Scholar
• Baker, E. (2006). Hydrogen bonding in biological macromolecules. In International tables for crystallography (pp. 546–552). Springer.
   Google Scholar
• Bell, E. W., & Zhang, Y. (2019). DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. Journal of Cheminformatics, 11(1), 40. https://doi.org/10.1186/s13321-019-0362-7
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Grigera, J. R., & Straatsma, T. P. (1987). The missing term in effective pair potentials. The Journal of Physical Chemistry, 91(24), 6269–6271. https://doi.org/10.1021/j100308a038
   Web of Science ®Google Scholar
• Bertrand, J. A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H. M., & Flocco, M. (2003). Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors. Journal of Molecular Biology, 333(2), 393–407. https://doi.org/10.1016/j.jmb.2003.08.031
   PubMed Web of Science ®Google Scholar
• Beshnova, D. A., Pereira, J., & Lamzin, V. S. (2017). Estimation of the protein-ligand interaction energy for model building and validation. Acta Crystallographica. Section D, Structural Biology, 73(Pt 3), 195–202. https://doi.org/10.1107/S2059798317003400
   PubMedGoogle Scholar
• Best, R. B., Zhu, X., Shim, J., Lopes, P. E. M., Mittal, J., Feig, M., & Mackerell, A. D. (2012). Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. Journal of Chemical Theory and Computation, 8(9), 3257–3273. https://doi.org/10.1021/ct300400x
   PubMed Web of Science ®Google Scholar
• Beurel, E., Grieco, S. F., & Jope, R. S. (2015). Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacology & Therapeutics, 148, 114–131. https://doi.org/10.1016/j.pharmthera.2014.11.016
   PubMed Web of Science ®Google Scholar
• Bhardwaj, V. K., Singh, R., Sharma, J., Das, P., & Purohit, R. (2020). Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase. Computer Methods and Programs in Biomedicine, 194, 105494. https://doi.org/10.1016/j.cmpb.2020.105494
   PubMed Web of Science ®Google Scholar
• Bhat, R., Xue, Y., Berg, S., Hellberg, S., Ormö, M., Nilsson, Y., Radesäter, A.-C., Jerning, E., Markgren, P.-O., Borgegård, T., Nylöf, M., Giménez-Cassina, A., Hernández, F., Lucas, J. J., Díaz-Nido, J., & Avila, J. (2003). Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. The Journal of Biological Chemistry, 278(46), 45937–45945. https://doi.org/10.1074/jbc.M306268200
   PubMed Web of Science ®Google Scholar
• Bhatia, N., Santos, M., Jones, L. W., Beckman, J. A., Penson, D. F., Morgans, A. K., & Moslehi, J. (2016). Cardiovascular effects of androgen deprivation therapy for the treatment of prostate cancer: ABCDE steps to reduce cardiovascular disease in patients with prostate cancer. Circulation, 133(5), 537–541. https://doi.org/10.1161/CIRCULATIONAHA.115.012519
   PubMed Web of Science ®Google Scholar
• Bustanji, Y., Taha, M. O., Almasri, I. M., Al-Ghussein, M. A., Mohammad, M. K., & Alkhatib, H. S. (2009). Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry, 24(3), 771–778. https://doi.org/10.1080/14756360802364377
   PubMed Web of Science ®Google Scholar
• Castro-Alvarez, A., Costa, A. M., & Vilarrasa, J. (2017). The performance of several docking programs at reproducing protein-macrolide-like crystal structures. Molecules, 22(1), 136. https://doi.org/10.3390/molecules22010136
   PubMed Web of Science ®Google Scholar
• Chang, L., Graham, P. H., Ni, J., Hao, J., Bucci, J., Cozzi, P. J., & Li, Y. (2015). Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance. Critical Reviews in Oncology/Hematology, 96(3), 507–517. https://doi.org/10.1016/j.critrevonc.2015.07.005
   PubMed Web of Science ®Google Scholar
• Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., & Pearl, L. H. (2001). Crystal structure of glycogen synthase kinase 3 beta: Structural basis for phosphate-primed substrate specificity and autoinhibition. Cell, 105(6), 721–732. https://doi.org/10.1016/s0092-8674(01)00374-9
   PubMed Web of Science ®Google Scholar
• David, C. C., & Jacobs, D. J. (2014). Principal component analysis: A method for determining the essential dynamics of proteins. Methods in Molecular Biology (Clifton, N.J.), 1084, 193–226. https://doi.org/10.1007/978-1-62703-658-0_11
   PubMedGoogle Scholar
• DeLano, W. (2002). PyMOL: An open-source molecular graphics tool. DeLano Scientific San Carlos.
   Google Scholar
• Domoto T., Pyko, I. V., Furuta, T., Miyashita, K., Uehara, M., & Shimasaki, T. (2016). Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Science, 107(10), 1363–1372. https://doi.org/10.1111/cas.13028
   PubMed Web of Science ®Google Scholar
• Du, X., Li, Y., Xia, Y.-L., Ai, S.-M., Liang, J., Sang, P., Ji, X.-L., & Liu, S.-Q. (2016). Insights into protein-ligand interactions: Mechanisms, models, and methods. International Journal of Molecular Sciences, 17(2), 144. https://doi.org/10.3390/ijms17020144
   PubMed Web of Science ®Google Scholar
• Durham, E., Dorr, B., Woetzel, N., Staritzbichler, R., & Meiler, J. (2009). Solvent accessible surface area approximations for rapid and accurate protein structure prediction. Journal of Molecular Modeling, 15(9), 1093–1108. https://doi.org/10.1007/s00894-009-0454-9
   PubMed Web of Science ®Google Scholar
• Ehianeta, T. S., Laval, S., & Yu, B. (2016). Bio- and chemical syntheses of mangiferin and congeners. BioFactors (Oxford, England), 42(5), 445–458. https://doi.org/10.1002/biof.1279
   PubMed Web of Science ®Google Scholar
• Eldar-Finkelman, H., & Martinez, A. (2011). GSK-3 inhibitors: Preclinical and clinical focus on CNS. Frontiers in Molecular Neuroscience, 4, 32. https://doi.org/10.3389/fnmol.2011.00032
   PubMed Web of Science ®Google Scholar
• Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Jr., Woodgett, J. R., & Mills, G. B. (2000). Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proceedings of the National Academy of Sciences of the United States of America, 97(22), 11960–11965. https://doi.org/10.1073/pnas.220413597
   PubMed Web of Science ®Google Scholar
• Ferreira de Freitas, R., & Schapira, M. (2017). A systematic analysis of atomic protein-ligand interactions in the PDB. MedChemComm, 8(10), 1970–1981. https://doi.org/10.1039/c7md00381a
   PubMed Web of Science ®Google Scholar
• Fiol, C. J., Mahrenholz, A. M., Wang, Y., Roeske, R. W., & Roach, P. J. (1987). Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. The Journal of Biological Chemistry, 262(29), 14042–14048.
   PubMed Web of Science ®Google Scholar
• Frame, S., Cohen, P., & Biondi, R. M. (2001). A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Molecular Cell, 7(6), 1321–1327. https://doi.org/10.1016/s1097-2765(01)00253-2
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. Epub 2015/04/04. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Goc, A., Al-Husein, B., Katsanevas, K., Steinbach, A., Lou, U., Sabbineni, H., DeRemer, D. L., & Somanath, P. R. (2014). Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo. Oncotarget, 5(3), 775–787. https://doi.org/10.18632/oncotarget.1770
   PubMedGoogle Scholar
• Grimes, C. A., & Jope, R. S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Progress in Neurobiology, 65(4), 391–426. https://doi.org/10.1016/s0301-0082(01)00011-9
   PubMed Web of Science ®Google Scholar
• Grosdidier, A., Zoete, V., & Michielin, O. (2011a). Fast docking using the CHARMM force field with EADock DSS. Journal of Computational Chemistry, 32(10), 2149–2159. https://doi.org/10.1002/jcc.21797
   PubMed Web of Science ®Google Scholar
• Grosdidier, A., Zoete, V., & Michielin, O. (2011b). SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Research, 39(Web Server issue), W270–W277. https://doi.org/10.1093/nar/gkr366
   PubMed Web of Science ®Google Scholar
• Guo, F., Huang, C., Liao, X., Wang, Y., He, Y., Feng, R., Li, Y., & Sun, C. (2011). Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Molecular Nutrition & Food Research, 55(12), 1809–1818. https://doi.org/10.1002/mnfr.201100392
   PubMed Web of Science ®Google Scholar
• Guo, F., Li, S. C., Wang, L., & Zhu, D. (2012). Protein-protein binding site identification by enumerating the configurations. BMC Bioinformatics, 13, 158. https://doi.org/10.1186/1471-2105-13-158
   PubMed Web of Science ®Google Scholar
• Guo, Y., Gupte, M., Umbarkar, P., Singh, A. P., Sui, J. Y., Force, T., & Lal, H. (2017). Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. Journal of Molecular and Cellular Cardiology, 110, 109–120. https://doi.org/10.1016/j.yjmcc.2017.07.011
   PubMed Web of Science ®Google Scholar
• Henriksen, E. J., & Dokken, B. B. (2006). Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Current Drug Targets, 7(11), 1435–1441. https://doi.org/10.2174/1389450110607011435
   PubMed Web of Science ®Google Scholar
• Hermida, M. A., Dinesh Kumar, J., & Leslie, N. R. (2017). GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Advances in Biological Regulation, 65, 5–15. https://doi.org/10.1016/j.jbior.2017.06.003
   PubMedGoogle Scholar
• Hess, B., & van der Vegt, N. F. (2006). Hydration thermodynamic properties of amino acid analogues: A systematic comparison of biomolecular force fields and water models. The Journal of Physical Chemistry. B, 110(35), 17616–17626. https://doi.org/10.1021/jp0641029
   PubMed Web of Science ®Google Scholar
• Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., & Woodgett, J. R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. The EMBO Journal, 12(2), 803–808. https://doi.org/10.1002/j.1460-2075.1993.tb05715.x
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Imran, M., Arshad, M. S., Butt, M. S., Kwon, J. H., Arshad, M. U., & Sultan, M. T. (2017). Mangiferin: A natural miracle bioactive compound against lifestyle related disorders. Lipids in Health and Disease, 16(1), 84. https://doi.org/10.1186/s12944-017-0449-y
   PubMedGoogle Scholar
• Jin, J., Tian, R., Pasculescu, A., Dai, A. Y., Williton, K., & Taylor, L. (2016). Mutational analysis of glycogen synthase kinase 3β protein kinase together with kinome-wide binding and stability studies suggests context-dependent recognition of kinases by the chaperone heat shock protein 90. Molecular and Cellular Biology, 36(6), 1007–1018. https://doi.org/10.1128/mcb.01045-15
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Kaminski, G. A., Stern, H. A., Berne, B. J., Friesner, R. A., Cao, Y. X., Murphy, R. B., Zhou, R., & Halgren, T. A. (2002). Development of a polarizable force field for proteins via ab initio quantum chemistry: First generation model and gas phase tests. Journal of Computational Chemistry, 23(16), 1515–1531. https://doi.org/10.1002/jcc.10125
   PubMed Web of Science ®Google Scholar
• Kramer, T., Schmidt, B., & Lo Monte, F. (2012). Small-molecule inhibitors of GSK-3: Structural insights and their application to Alzheimer's disease models. International Journal of Alzheimer's Disease, 2012, 381029. https://doi.org/10.1155/2012/381029
   PubMedGoogle Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lal, H., Ahmad, F., Woodgett, J., & Force, T. (2015). The GSK-3 family as therapeutic target for myocardial diseases. Circulation Research, 116(1), 138–149. https://doi.org/10.1161/CIRCRESAHA.116.303613
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lee, M. R., Tsai, J., Baker, D., & Kollman, P. A. (2001). Molecular dynamics in the endgame of protein structure prediction. Journal of Molecular Biology, 313(2), 417–430. https://doi.org/10.1006/jmbi.2001.5032
   PubMed Web of Science ®Google Scholar
• Lemkul, J. (2019). From proteins to perturbed hamiltonians: A suite of tutorials for the GROMACS-2018 molecular simulation package, v1.0. Living Journal of Computational Molecular Science, 1(1). https://doi.org/10.33011/livecoms.1.1.5068
   Google Scholar
• Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., & Zakai, N. (2010). Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology. CA: A Cancer Journal for Clinicians, 60(3), 194–201. https://doi.org/10.3322/caac.20061
   PubMed Web of Science ®Google Scholar
• Li, B., Thrasher, J. B., & Terranova, P. (2015). Glycogen synthase kinase-3: A potential preventive target for prostate cancer management. Urologic Oncology, 33(11), 456–463. https://doi.org/10.1016/j.urolonc.2015.05.006
   PubMed Web of Science ®Google Scholar
• Linding, R., Jensen, L. J., Ostheimer, G. J., van Vugt, M. A. T. M., Jørgensen, C., Miron, I. M., Diella, F., Colwill, K., Taylor, L., Elder, K., Metalnikov, P., Nguyen, V., Pasculescu, A., Jin, J., Park, J. G., Samson, L. D., Woodgett, J. R., Russell, R. B., Bork, P., Yaffe, M. B., & Pawson, T. (2007). Systematic discovery of in vivo phosphorylation networks. Cell, 129(7), 1415–1426. https://doi.org/10.1016/j.cell.2007.05.052
   PubMed Web of Science ®Google Scholar
• Luo, G., Chen, L., Burton, C. R., Xiao, H., Sivaprakasam, P., Krause, C. M., Cao, Y., Liu, N., Lippy, J., Clarke, W. J., Snow, K., Raybon, J., Arora, V., Pokross, M., Kish, K., Lewis, H. A., Langley, D. R., Macor, J. E., & Dubowchik, G. M. (2016). Discovery of Isonicotinamides as highly selective, brain penetrable, and orally active glycogen synthase kinase-3 inhibitors. Journal of Medicinal Chemistry, 59(3), 1041–1051. https://doi.org/10.1021/acs.jmedchem.5b01550
   PubMed Web of Science ®Google Scholar
• Mancinelli, R., Carpino, G., Petrungaro, S., Mammola, C. L., Tomaipitinca, L., Filippini, A., Facchiano, A., Ziparo, E., & Giampietri, C. (2017). Multifaceted roles of GSK-3 in cancer and autophagy-related diseases. Oxidative Medicine and Cellular Longevity, 2017, 4629495–4622018. https://doi.org/10.1155/2017/4629495
   PubMed Web of Science ®Google Scholar
• Mangangcha, I. R., Malik, M. Z., Kucuk, O., Ali, S., & Singh, R. K. B. (2019). Identification of key regulators in prostate cancer from gene expression datasets of patients. Scientific Reports, 9(1), 16420. https://doi.org/10.1038/s41598-019-52896-x
   PubMedGoogle Scholar
• Martin, S. A., Souder, D. C., Miller, K. N., Clark, J. P., Sagar, A. K., Eliceiri, K. W., Puglielli, L., Beasley, T. M., & Anderson, R. M. (2018). GSK3β regulates brain energy metabolism. Cell Reports, 23(7), 1922–1931.e4. https://doi.org/10.1016/j.celrep.2018.04.045
   PubMed Web of Science ®Google Scholar
• Martinez, L. (2015). Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS One, 10(3), e0119264. https://doi.org/10.1371/journal.pone.0119264
   PubMed Web of Science ®Google Scholar
• Matkowski, A., Kus, P., Goralska, E., & Wozniak, D. (2013). Mangiferin - A bioactive xanthonoid, not only from mango and not just antioxidant. Mini - Reviews in Medicinal Chemistry, 13(3), 439–455.
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Morris, G. M., & Lim-Wilby, M. (2008). Molecular docking. Methods in Molecular Biology (Clifton, N.J.), 443, 365–382. https://doi.org/10.1007/978-1-59745-177-2_19
   PubMedGoogle Scholar
• Nagini, S., Sophia, J., & Mishra, R. (2019). Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer. Seminars in Cancer Biology, 56, 25–36. https://doi.org/10.1016/j.semcancer.2017.12.010
   PubMed Web of Science ®Google Scholar
• Ng, L., Kaur, P., Bunnag, N., Suresh, J., Sung, I., Tan, Q., Gruber, J., & Tolwinski, N. (2019). WNT Signaling in Disease. Cells, 8(8), 826–807. https://doi.org/10.3390/cells8080826
   PubMed Web of Science ®Google Scholar
• Pandey, M. K., & DeGrado, T. R. (2016). Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging. Theranostics, 6(4), 571–593. https://doi.org/10.7150/thno.14334
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Reddy, M. R., Reddy, C. R., Rathore, R. S., Erion, M. D., Aparoy, P., Reddy, R. N., & Reddanna, P. (2014). Free energy calculations to estimate ligand-binding affinities in structure-based drug design. Current Pharmaceutical Design, 20(20), 3323–3337. https://doi.org/10.2174/13816128113199990604
   PubMed Web of Science ®Google Scholar
• Redenti, S., Marcovich, I., De Vita, T., Pérez, C., De Zorzi, R., Demitri, N., Perez, D. I., Bottegoni, G., Bisignano, P., Bissaro, M., Moro, S., Martinez, A., Storici, P., Spalluto, G., Cavalli, A., & Federico, S. (2019). A triazolotriazine-based dual GSK-3β/CK-1δ ligand as a potential neuroprotective agent presenting two different mechanisms of enzymatic inhibition. ChemMedChem, 14(3), 310–314. https://doi.org/10.1002/cmdc.201800778
   PubMed Web of Science ®Google Scholar
• Saitoh, M., Kunitomo, J., Kimura, E., Iwashita, H., Uno, Y., Onishi, T., Uchiyama, N., Kawamoto, T., Tanaka, T., Mol, C. D., Dougan, D. R., Textor, G. P., Snell, G. P., Takizawa, M., Itoh, F., & Kori, M. (2009). 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability. Journal of Medicinal Chemistry, 52(20), 6270–6286. https://doi.org/10.1021/jm900647e
   PubMed Web of Science ®Google Scholar
• Sarker, D., Reid, A. H., Yap, T. A., & de Bono, J. S. (2009). Targeting the PI3K/AKT pathway for the treatment of prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15(15), 4799–4805. https://doi.org/10.1158/1078-0432.CCR-08-0125
   PubMed Web of Science ®Google Scholar
• Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005). PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Research, 33(Web Server issue), W363–7. https://doi.org/10.1093/nar/gki481
   PubMed Web of Science ®Google Scholar
• Shinkafi, T. S., Kaushik, A., Mahmood, A., Tiwari, A. K., Alam, M. M., & Akhter, M. (2019). Computational prediction and experimental validation of the activator function of C2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone on pancreatic and hepatic hexokinase. Journal of Biomolecular Structure and Dynamics, 38(10), 2976-2987. https://doi.org/10.1080/07391102.2019.1650829
   Google Scholar
• Sneha, P., & Doss, C. G. (2016). Molecular dynamics: New Frontier in personalized medicine. Advances in Protein Chemistry and Structural Biology, 102, 181–224. https://doi.org/10.1016/bs.apcsb.2015.09.004
   PubMed Web of Science ®Google Scholar
• Stamos, J. L., Chu, M. L., Enos, M. D., Shah, N, & Weis, W. I. (2014). Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6. Elife, 3, e01998. https://doi.org/10.7554/eLife.01998
   PubMed Web of Science ®Google Scholar
• Sun, H., Jiang, Y. J., Yu, Q. S., Luo, C. C., & Zou, J. W. (2008). Effect of mutation K85R on GSK-3beta: Molecular dynamics simulation. Biochemical and Biophysical Research Communications, 377(3), 962–965. https://doi.org/10.1016/j.bbrc.2008.10.096
   PubMed Web of Science ®Google Scholar
• Sutherland, C. (2011). What are the bona fide GSK3 substrates? International Journal of Alzheimer's Disease, 2011, 505607. https://doi.org/10.4061/2011/505607
   PubMedGoogle Scholar
• ter Haar, E., Coll, J. T., Austen, D. A., Hsiao, H. M., Swenson, L., & Jain, J. (2001). Structure of GSK3beta reveals a primed phosphorylation mechanism. Nature Structural Biology, 8(7), 593–596. https://doi.org/10.1038/89624
   PubMedGoogle Scholar
• Tront, J. S., Huang, Y., Fornace, A. J., Fornace, A. A., Hoffman, B., & Liebermann, D. A. (2010). Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress. Cancer Research, 70(23), 9671–9681. https://doi.org/10.1158/0008-5472.Can-10-2177
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Raman, E. P., & MacKerell, A. D. Jr. (2012). Automation of the CHARMM general force field (CGenFF) II: Assignment of bonded parameters and partial atomic charges. Journal of Chemical Information and Modeling, 52(12), 3155–3168. https://doi.org/10.1021/ci3003649
   PubMed Web of Science ®Google Scholar
• Wang, Z., Sun, H., Yao, X., Li, D., Xu, L., Li, Y., Tian, S., & Hou, T. (2016). Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: The prediction accuracy of sampling power and scoring power. Physical Chemistry Chemical Physics: PCCP, 18(18), 12964–12975. https://doi.org/10.1039/c6cp01555g
   PubMed Web of Science ®Google Scholar
• Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ghio, C., Alagona, G., Profeta, S., & Weiner, P. (1984). A new force field for molecular mechanical simulation of nucleic acids and proteins. Journal of the American Chemical Society, 106(3), 765–784. https://doi.org/10.1021/ja00315a051
   Web of Science ®Google Scholar
• Zhang, C., Vasmatzis, G., Cornette, J. L., & DeLisi, C. (1997). Determination of atomic desolvation energies from the structures of crystallized proteins. Journal of Molecular Biology, 267(3), 707–726. https://doi.org/10.1006/jmbi.1996.0859
   PubMed Web of Science ®Google Scholar
• Zhang, D., & Lazim, R. (2017). Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Scientific Reports, 7, 44651. https://doi.org/10.1038/srep44651
   PubMed Web of Science ®Google Scholar
• Zhu, J., Wu, Y., Xu, L., & Jin, J. (2020). Theoretical studies on the selectivity mechanisms of glycogen synthase kinase 3β (GSK3β) with pyrazine ATP-competitive inhibitors by 3DQSAR, molecular docking, molecular dynamics simulation and free energy calculations. Current Computer-Aided Drug Design, 16(1), 17–30. https://doi.org/10.2174/1573409915666190708102459
   PubMed Web of Science ®Google Scholar